Browse Category

NYSE:CGC News 12 December 2025 - 13 December 2025

Top Stock Gainers Today (Dec. 12, 2025): Cannabis Stocks TLRY, CGC Rally on Rescheduling Buzz; Rivian and Lululemon Lead Big-Cap Winners

Top Stock Gainers Today (Dec. 12, 2025): Cannabis Stocks TLRY, CGC Rally on Rescheduling Buzz; Rivian and Lululemon Lead Big-Cap Winners

Here are the top gainers in the U.S. stock market on Dec. 12, 2025—plus the news, analyst takes, and after-hours movers investors are watching. NEW YORK — Dec. 12, 2025 (Updated: 6:00 p.m. ET) Wall Street finished a choppy Friday with a familiar tug-of-war: mega-cap tech weakness pulling the major indexes lower, while pockets of the market lit up with explosive upside. The S&P 500 slid 1.1% to 6,827.41, the Nasdaq Composite fell 1.7% to 23,195.17, and the Dow Jones Industrial Average declined 0.5% to 48,458.05. Tech-heavy pressure showed up in names tied to the AI trade—Broadcom dropped 11.4%, Nvidia fell 3.3%, and Oracle slid 4.5%—even as the 10-year Treasury yield edged
US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

Updated: Friday, December 12, 2025 — 6:00 a.m. ET SEO summary: Here are the biggest US stock market premarket gainers today (NYSE/Nasdaq) and the news driving them, including Lululemon’s earnings and CEO transition, a cannabis-stock surge tied to marijuana rescheduling headlines, and earnings-driven jumps in Mitek and Quanex. Nasdaq+4StockAnalysis+4Reuters+4 US stock futures were mixed early Friday, with investors balancing a post-Fed backdrop against renewed questions around big-tech AI spending after Oracle’s latest move and broader positioning into year-end. Reuters Below is a detailed look at the top premarket gainers as of about 6:00 a.m. ET, plus the headlines, forecasts, and analyst takes circulating on 12/12/2025. Top premarket stock gainers right now (as of ~6:00 a.m. ET) These are the leading percentage gainers in

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
New York, Feb 7, 2026, 07:20 EST — Market closed. Kenvue Inc shares ended Friday up 0.3% at $18.13, keeping the Tylenol maker close to the value implied by its agreed sale to Kimberly-Clark as investors headed into the weekend. With U.S. markets shut, Monday’s open is likely to be less about day-to-day company chatter and more about deal positioning. Kenvue is trading like a merger stock, where the key input is the gap between KVUE’s price and the value of what the buyer is offering. That matters now because the gap is small and jumpy. A move in Kimberly-Clark
IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

7 February 2026
IREN shares closed up 5.1% at $41.83 Friday after reporting a $155.4 million quarterly loss and $184.7 million in revenue. The company announced $3.6 billion in GPU financing for its Microsoft contract, with $2.8 billion in cash as of Jan. 31. Bitcoin mining revenue fell, while AI cloud services rose. Traders await bitcoin’s weekend move and Monday’s market reaction.
Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

7 February 2026
Cadence Bank shares have been delisted following Huntington Bancshares’ takeover, with each Cadence share converted into 2.475 Huntington shares. Huntington closed Friday at $19.27 and named Senthil Kumar as chief risk officer ahead of new regulatory requirements. The merger leaves Cadence as a brand under Huntington, with customer account conversions planned for mid-2026. Huntington executives will address investors at a UBS conference on Tuesday.
Go toTop